Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using ¹⁸F-FDG PET/CT

J Nucl Med. 2020 Sep;61(9):1405. doi: 10.2967/jnumed.120.243444. Epub 2020 Mar 13.

Authors

Angelo Castello, Egesta Lopci¹

Affiliation

¹ Humanitas Clinical and Research Hospital-IRCCSVia Manzoni 56, 20089Rozzano, Milan, ItalyE-mail: egesta.lopci@gmail.com.

PMID: 32169909
DOI: 10.2967/jnumed.120.243444

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Fluorodeoxyglucose F18
Humans
Lung Neoplasms*
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Radiopharmaceuticals

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18